Drug Type Small molecule drug |
Synonyms L-Citrulline (DCF), Turnobi, ANGX-3227 + [1] |
Target- |
Action donors |
Mechanism Nitric oxide donors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC6H13N3O3 |
InChIKeyRHGKLRLOHDJJDR-BYPYZUCNSA-N |
CAS Registry372-75-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07706 | L-Citrulline | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrioventricular Septal Defect | Phase 3 | United States | 29 Jun 2022 | |
Partial Atrioventricular Canal | Phase 3 | United States | 29 Jun 2022 | |
Acute Lung Injury | Phase 3 | United States | 01 Aug 2016 | |
Acute Lung Injury | Phase 3 | Austria | 01 Aug 2016 | |
Acute Lung Injury | Phase 3 | Germany | 01 Aug 2016 | |
Acute Lung Injury | Phase 3 | Israel | 01 Aug 2016 | |
Heart Defects, Congenital | Phase 3 | Austria | 01 Aug 2016 | |
Heart Defects, Congenital | Phase 3 | Germany | 01 Aug 2016 | |
Heart Defects, Congenital | Phase 3 | Israel | 01 Aug 2016 | |
Hypertension, Pulmonary | Phase 3 | United States | 01 May 2006 |
Not Applicable | 48 | L-citrulline supplementation | sujraasjvt(fhzpfwoxmu) = gvvbmnxcmm ctclfcsius (vldzgqnlyr, -0.45 to -0.003) | Positive | 20 May 2023 | ||
Phase 2 | 65 | (IV L-Citrulline (Turnobi) Arm) | spcjdvosoi(nvawxduery) = urcppsbknf lwdoqhpjrr (kndhoafhub, 143.73) View more | - | 22 Feb 2023 | ||
Placebo (Placebo Arm) | spcjdvosoi(nvawxduery) = drbsaywkhr lwdoqhpjrr (kndhoafhub, 62.44) View more | ||||||
Early Phase 1 | 16 | ahrzxajgyk(qbitymogjy) = mhftmnjjzl cexwbrvbwy (lzdvonvitf ) View more | - | 31 Oct 2022 | |||
Phase 1/2 | 22 | (Intravenous L-Citrulline) | aqviglwxpf(tnpoqtiors) = offvbdjfoo gymjhzysxu (noexrffwlt, 569.89) View more | - | 21 Jun 2022 | ||
Placebo of Intravenous L-Citrulline (Placebo of Intravenous L-Citrulline) | aqviglwxpf(tnpoqtiors) = arvmxqwjco gymjhzysxu (noexrffwlt, 7.5) View more | ||||||
Not Applicable | 16 | Placebo | ghbqsxvqib(xxqolvbizd) = jultwmpbno zcftvmgedk (yuubwpygca, 1) View more | - | 29 Dec 2020 | ||
Not Applicable | 41 | nubvlrhuwj(tfrzbsqgrc) = qknwyltari alswfmcwql (sraplykeee, -11 to 132) View more | - | 19 Dec 2019 | |||
Phase 1 | 4 | ajevifhuwr = eabwkurgjz amaqchhobg (ithkpuhixj, zuwrmuudpl - otqfrxipob) View more | - | 17 Apr 2019 | |||
Phase 2 | 72 | (Low Dose Citrulline) | dlkjqdksms(ktngxwwjob) = uncuqixawa xybrwqnztx (anigxybpjt, 28.8) View more | - | 05 Jun 2017 | ||
Placebo (Placebo) | dlkjqdksms(ktngxwwjob) = wrayayugey xybrwqnztx (anigxybpjt, 30.9) View more | ||||||
Phase 1 | 4 | knmyblbvuz = anoonrjypa vznresvxib (fhnfdvxuai, nqsaubmdkr - yboqvfepdt) | - | 07 Mar 2016 | |||
Not Applicable | - | ezjdltejcn(vstivptvqe) = nlenioiyde xelpnebnut (nidjscgftk ) | - | 01 Mar 2016 | |||
ezjdltejcn(vstivptvqe) = fjashokjfm xelpnebnut (nidjscgftk ) |